We anticipate that BIRC5 mRNA expression profiling in biopsies will be most useful as a diagnostic tool for screening and identifying people at a higher likelihood of developing the aggressive BC subtypes-TNBC, even though further large-scale validation is necessary. This evidence concerns the gene BIRC5 and breast cancer.